May 06, 2022 / 03:30PM GMT
Operator
Good afternoon. This is the Chorus Call conference operator. Welcome and thank you for joining the DiaSorin First Quarter 2022 Results Conference Call. (Operator Instructions)
At this time, I would like to turn the conference over to Mr. Carlo Rosa, CEO of DiaSorin. Please go ahead, sir.
Carlo Rosa - DiaSorin S.p.A. - CEO, GM & Executive Director
Thank you, operator, and ladies and gentlemen, Good morning, good afternoon. [As announced this week], I will make some few comments, as usual at constant exchange rate and then the CFO, Mr. Pedron, is going to take you through the numbers.
Okay. So first, as you know, we have been slightly changing our reporting system after the acquisition of Luminex. So now we have the business, which is divided in 3 buckets. We have the immuno side and in immuno side we have all the technologies that start from CLIA, the ELISA technologies. And we have the molecular bucket, and then we have the license technology bucket. So let me start to talk about immuno.
Immuno, we look at the ex the COVID part
Q1 2022 DiaSorin SpA Earnings Call Transcript
May 06, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers